This inventor holds 1 USPTO granted patent. Top assignee: Reddy US Therapeutics, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Work of Bhatlapenumarthy Sesha Sridevi Alluri
Introduction
Bhatlapenumarthy Sesha Sridevi Alluri is an influential inventor based in Hyderabad, Telangana, India. With a focus on medical innovations, he has made significant contributions to the field through his patented inventions.
Latest Patents
Alluri holds a patent for his groundbreaking invention titled "Medical devices employing triazine compounds and compositions thereof." This invention pertains to methods and compositions that address pathophysiological conditions triggered by inflammatory responses. Specifically, it targets compounds capable of inhibiting the production of glycated proteins that induce inflammation in endothelial cells. Furthermore, the invention addresses smooth muscle cell proliferation by modulating heparan sulfate proteoglycans (HSPGs) like Perlecan. This groundbreaking work is aimed at treating vascular occlusive conditions characterized by smooth muscle proliferation, such as restenosis and atherosclerosis.
Career Highlights
Currently, Bhatlapenumarthy Sesha Sridevi Alluri is associated with Reddy US Therapeutics, Inc., where he continues to innovate in the medical field. His work is instrumental in developing new therapeutic approaches that could potentially transform patient care and treatment methodologies.
Collaborations
Throughout his career, Alluri has collaborated with notable professionals in the field, including Richard T Timmer and Christopher W Alexander. These partnerships have allowed for the exploration of innovative solutions to complex medical challenges, further enhancing the impact of their joint research efforts.
Conclusion
Bhatlapenumarthy Sesha Sridevi Alluri's contributions to the field of medical devices underscore the essential role of innovation in addressing healthcare challenges. His patented work presents promising advancements in treating inflammatory responses and vascular occlusive conditions. As he continues to work at Reddy US Therapeutics, Inc., the medical community eagerly anticipates further innovations that could arise from his expertise and collaborative efforts.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile